Zimbabwe has rejected a significant US health deal valued at $367m (£272m) spanning five years because of Washington's insistence on confidential data.
This rejection became public following a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the deal was "lopsided".
A government representative later stated that the US was requesting biological samples for research and profit while was not willing to share the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for continued talks to secure a agreement agreeable to all parties so the nation's vital HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision comes after a comparable situation in Kenya, where a court suspended a related health funding agreement after legal challenges were raised about the security of citizens' health data.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had administered assistance for the US government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral deals to boost transparency and responsibility.
As per statements, 16 nations in Africa have so far signed these new health pacts, constituting more than $18.3bn in committed funds.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment through American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any medical innovations – like new medicines or tests – that might be developed from that provided information," Mangwana explained.
"Put simply, our country would supply the raw materials for scientific discovery without any certainty that the end products would be accessible to our people if a future disease outbreak arise."
Sovereignty and Global Health
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were upending systems previously established through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.
"This system is designed to guarantee that when a country contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to ongoing discussions with our American counterparts on how future collaboration could be structured in a manner that respects the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but suggested that negotiations must proceed given that a large portion of the nation's HIV programmes were funded by foreign aid.
"In cases where specific concerns exist, including those involving information security or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," it added.
The situation emphasises the complex debate between receiving crucial foreign assistance and protecting national sovereignty in an ever more interconnected world.